Drug and pharmaceutical recalls
754 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIDo not use Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi dextrose injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi sodium chloride injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass II0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIDo not use Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi sodium chloride injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugFresenius Kabi USA, LLCClass IIStop using Fresenius Kabi saline injection
Lack of Assurance of Sterility
- 2026-04-15FDA-DrugCipla USA, Inc.Class IIStop using Cipla Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
- 2026-04-15FDA-DrugCipla USA, Inc.Class IIDo not use Cipla Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
- 2026-04-08FDA-PRBlaine Labs, IncStop using Blaine Labs wound care gel
Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the consumer level due to microbial contamination.
- 2026-04-08FDA-DrugAmneal Pharmaceuticals, LLCClass IStop using Amneal Magnesium Sulfate IV bags
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
- 2026-04-08FDA-DrugAppco Pharma LLCClass IIStop using recalled prazosin hydrochloride capsules
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- 2026-04-08FDA-DrugAppco Pharma LLCClass IIStop using Appco Pharma prazosin capsules
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- 2026-04-08FDA-DrugAppco Pharma LLCClass IIStop taking recalled prazosin capsules
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled artificial tears eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled eye drops immediately
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled redness relief eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled sterile eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled lubricating eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled Dry Eye Relief Eye Drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using Advanced Relief eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugK.C. Pharmaceuticals, IncClass IIStop using recalled sterile eye drops
Lack of Assurance of Sterility
- 2026-04-08FDA-DrugAmneal Pharmaceuticals, LLCClass IIStop using Amneal tramadol tablets
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
- 2026-04-08FDA-DrugALEMBIC PHARMACEUTICALS, INC.Class IIStop using Alembic Bromfenac eye drops
Failed Impurities/Degradation Specifications: out of specification at the time of testing i.e. 20th month stability testing.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief